North America Cardiovascular Devices Market Drivers and Forecasts by 2027

The North America cardiovascular devices market is expected to reach US$ 27,058.9 Mn in 2027 from US$ 15,299.7 Mn in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027.

The growth of the market is driven by the factors such as, rising developments for cardiovascular devices and rising geriatric population. However, the cardiovascular devices market is likely to slower down its growth due to the rigorous regulations for approval in the region.

The rising population of the elderly people is the major cause of the heart diseases in the region. The heart diseases are mostly pone to the elderly people due to weak immunity and major other health problems. For instance, the number of Americans above the age of 65 and older is anticipated to grow more than double from US$ 46 million in 2016 to above US$ 98 million by 2060, and the 65-and-older age group’s share in the world’s population will grow around 24%from 15 percent. In addition, as per the report of UN, in 2012, the number of older persons (aged 60 years or over) is expected to more than double. The number is estimated to reach around 2 billion in 2050 from 841 million in 2013. The number of older persons in the world is anticipated to be US$ 1.4 billion in 2030 and US$ 2.1 billion in 2050, and will rise above US$ 3.1 billion in 2100. The elderly population are more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. The major reason for the disease are related to the structural and functional changes in the cardiovascular system associated with the aging.

The rising geriatric population in the region leads to the cardiovascular disease which will require the cardiovascular devices for their treatment. These factors are likely to grow the market in the coming years.

US is expected to lead the market in the North America region owing to increasing prevalence of cardiovascular diseases, rising incidences of the high blood pressure and growing R&D in medical technology in the country. Moreover, the country has several hospitals, super specialty hospitals which offers diagnostic and treatment services for the cardiovascular diseases. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.

Maxico Cardiovascular Devices Market Revenue and Forecasts to 2027 ( US$ Mn)

NORTH AMERICA CARDIOVASCULAR DEVICES – MARKET SEGMENTATION

By Device

• Electrocardiography (ECG)
• Pacemaker
• Stent
• Defibrillator
• Cardiac Catheter
• Guidewire
• Heart Valve
• Event Monitor
• Others

By Application

• Coronary Heart Disease
• Sudden Cardiac Arrest
• Stroke
• Cerebrovascular Heart Disease
• Others

By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Cardiac Centers

By Geography

• North America

  • US
  • Canada
  • Mexico

Company Profiles

• Medtronic
• Boston Scientific Corporation
• Abbott
• Biosense Webster, Inc. (Johnson and Johnson)
• General Electric Company
• Koninklijke Philips N.V
• Siemens AG,
• BD
• B. Braun Melsungen AG
• Edwards Lifesciences Corporation.

North America Cardiovascular Devices Report Scope